GRX1

PF3D7_0306300 (GRX1) is a classical 12.4 kDa dithiol glutaredoxin of Plasmodium falciparum that carries out glutathione-dependent thiol–disulfide exchange through its CPYC active-site motif (PMID:11479312). It displays glutathione:HEDS transhydrogenase activity detectable in trophozoite extracts across multiple parasite strains and reduces heterologous (Trypanosoma brucei) ribonucleotide reductase in vitro, establishing it as an enzymatically active, GSH-dependent oxidoreductase (PMID:11479312). GRX1 efficiently catalyzes protein deglutathionylation and is itself a substrate of S-glutathionylation, placing it within the regulation of the parasite glutathionylome (PMID:21595565). Its atomic-resolution crystal structure confirms a conserved GSH-binding site built from the CXXC, TVP and CDD motifs together with Lys26 and Gln/Arg63, and reveals polar/charged substitutions that add hydrogen bonds and salt bridges not present in other glutaredoxins (PMID:24419382); biophysically, the protein folds via reversible two-state unfolding and is conformationally stable across pH 3.0–11.0 with peak thermostability at pH 8.0 (PMID:20006670). Beyond these in vitro biochemical, structural and biophysical characterizations, the in vivo physiological substrates and cellular role of GRX1 in the parasite have not been characterized in the available corpus.

1. 2001 High

   Establishing whether the P. falciparum genome encodes a functional classical glutaredoxin resolved whether the parasite possesses a dedicated glutathione-dependent thiol-disulfide oxidoreductase; the CPYC-motif protein was shown to be catalytically active.

   Evidence In vitro HEDS transhydrogenase and insulin reduction assays with recombinant protein, plus transhydrogenase activity in trophozoite extracts from multiple strains

   PMID:11479312

   Open questions at the time

   • Ribonucleotide reductase substrate was heterologous (T. brucei), not the P. falciparum enzyme
   • No demonstration of endogenous physiological substrates in the parasite
   • No loss-of-function or essentiality data
2. 2009 Medium

   Determining the folding and stability behavior of GRX1 addressed how robust the enzyme is as a protein scaffold, showing reversible two-state unfolding and broad pH/thermal stability.

   Evidence Guanidine hydrochloride and pH-dependent thermal denaturation of purified recombinant protein with stability curve analysis

   PMID:20006670

   Open questions at the time

   • No functional mutagenesis linking stability to catalysis
   • Biophysical study of isolated protein, not in a cellular context
3. 2011 Medium

   Defining the catalytic repertoire of GRX1 beyond simple transhydrogenase activity showed it catalyzes protein deglutathionylation and is itself glutathionylated, embedding it in glutathionylome regulation.

   Evidence Enzymatic deglutathionylation assays and affinity purification of biotin-maleimide-tagged glutathionylated proteins with proteomics

   PMID:21595565

   Open questions at the time

   • Specific in vivo deglutathionylation targets in the parasite not individually validated
   • Functional consequence of GRX1 self-glutathionylation unresolved
4. 2013 High

   Solving the crystal structure answered how GRX1 recognizes glutathione at atomic resolution, identifying the conserved GSH-binding site and Plasmodium-specific polar/charged substitutions.

   Evidence X-ray crystallography with S-SAD phasing and structural comparison to other glutaredoxins

   PMID:24419382

   Open questions at the time

   • Active-site Cys29 captured in an alternate conformation due to radiation damage
   • No structure of substrate- or GSH-bound complex
   • Functional significance of the parasite-specific substitutions not tested

• The endogenous physiological substrates, cellular localization, essentiality, and in vivo redox role of GRX1 in the parasite life cycle remain undefined.
• No genetic knockout/knockdown to establish essentiality
• No identified native P. falciparum protein substrates in vivo
• No subcellular localization data in the corpus